Low-dose methotrexate as a therapeutic candidate for schizophrenia: triangulating evidence from real-world data, knowledge graphs, and rodent model

Neuroscience Applied 2026 Open access

Read full text
Authors: F. Corsi-Zuelli, T. Lima, M. Taquet, A. Souza, D. Colodete, N. Rodrigues Silva, F. Verza, E. Del-Bel, P. Louzada-Júnior, C.M. Del-Ben, Guimarães F.S., Helder I. Nakaya
+3 more Felipe V. Gomes, Rachel Upthegrove, B. Deakin
DOI: 10.1016/j.nsa.2025.106321
Cited by: 0

Fields of Study & Subjects

Schizophrenia research and treatment Tryptophan and brain disorders Bioinformatics and Genomic Networks

Publication details

Journal / source
Neuroscience Applied
Volume
5
Pages
106321–106321
Publication date
1 January 2026
Language
EN